WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its fiscal second quarter and six-months ended March 31, 2015 financial results before the U.S. markets open on May 7, 2015. Enanta management will host a conference call at 8:30 a.m. ET to discuss these results and Enanta’s research and development pipeline.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
